MedPlus subsidiary faces temporary drug license suspension, minimal revenue impact

MedPlus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, received a three-day suspension order for a drug license at a store located in Nagole X Roads, Shameerpet, Telangana. The order, received on November 8, 2025, falls under Rule 65 of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945.

The company estimates a potential revenue loss of approximately Rs 1.73 lacs due to this suspension. This disclosure was made in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and referenced SEBI Circulars dated July 13, 2023, and December 31, 2024.

Manoj Kumar Srivastava, company secretary & compliance officer, digitally signed the announcement. The company indicated that the information is also available on its website and on the websites of BSE Limited and National Stock Exchange of India Ltd.